1.
Chinese Journal of Immunology
;
(12): 636-641, 2018.
Article
in Chinese
| WPRIM
| ID: wpr-702789
ABSTRACT
RA has been associated with a significantly increased risk of coronary heart disease compare to the general population because of dyslipidemia.Anti-rheumatic drugs have various effects on lipid profile,which in part appear pro-atherogenic.The aim of this review is to summarize the current knowledge on the effects of synthetic and biological disease modifying antirheumatic drugs for the treatment of RA on lipid profil,so the cardiovascular safety for antirheumatic drugs would be valuable.